Insider sale
DYNE THERAPEUTICS, INC.
$1.02M
50.53K shares
What this filing means
ATLAS VENTURE FUND XI, L.P. plans to sell 50.53K shares of DYNE THERAPEUTICS, INC. valued at approximately $1.02M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/24/2026ACC: 0001628280-26-045293
10% Owner
Since Sep 2020
50.53K
Shares to sell
$1.02M
Approx. market value
50.53K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Private Placement
Cash
7/31/2020
50.53KTotal acquired50.53K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/31/2020 | Private Placement Cash | 50.53K | — |
| Total | 50.53K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
50.53K
Market value
$1.02M
6/24/2026
Total
Units
50.53K
Value
$1.02M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
6/24/2026 | 50.53K | $1.02M | Nasdaq | Planned |
| Total | 50.53K | $1.02M | ||